BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 6056914)

  • 21. On the estimation of local effective perfusion pressure in patients with obliterative arterial disease by means of external compression over a Xenon-133 depot.
    Nilsén R; Dahn I; Lassen NA; Westling H
    Scand J Clin Lab Invest Suppl; 1967; 99():29-30. PubMed ID: 6056929
    [No Abstract]   [Full Text] [Related]  

  • 22. On the conservative treatment of severe ischemia of the leg.
    Dahn I; Ekman CA; Lassen NA; Nilsén R; Westling H
    Scand J Clin Lab Invest Suppl; 1967; 99():160-5. PubMed ID: 4293529
    [No Abstract]   [Full Text] [Related]  

  • 23. Regression of peripheral atherosclerosis during therapy with high doses of nicotinic acid.
    Ost CR; Sténson S
    Scand J Clin Lab Invest Suppl; 1967; 99():241-5. PubMed ID: 6056927
    [No Abstract]   [Full Text] [Related]  

  • 24. Exercise and intermittent claudication. Blood flow in the calf muscle during walking studied by the xenon-133 clearance method.
    Alpert JS; Larsen OA; Lassen NA
    Circulation; 1969 Mar; 39(3):353-9. PubMed ID: 4885945
    [No Abstract]   [Full Text] [Related]  

  • 25. [New data on vasoactive drug. Patients with peripheral arterial occlusive disease walk twice as long].
    MMW Fortschr Med; 2002 May; 144(21):54. PubMed ID: 12134429
    [No Abstract]   [Full Text] [Related]  

  • 26. Simultaneouus flow and pressure measurements in intermittent claudication.
    Lewis JD; Papathanaiou C; Yao ST; Eastcott HH
    Br J Surg; 1972 Jun; 59(6):418-22. PubMed ID: 5031187
    [No Abstract]   [Full Text] [Related]  

  • 27. Evaluation of arterial insufficiency of the legs. A comparison of arteriography and the 133Xe walking test.
    Alpert JS; Larsen OA; Lassen NA
    Cardiovasc Res; 1968 Apr; 2(2):161-9. PubMed ID: 5656308
    [No Abstract]   [Full Text] [Related]  

  • 28. [Intermittent claudication].
    Malińkski B; Zasada W
    Wiad Lek; 1983 Jun; 36(12):987-92. PubMed ID: 6356618
    [No Abstract]   [Full Text] [Related]  

  • 29. [Arterial insufficiency: spontaneous course in intermittent claudication with short history].
    Broomé A
    Lakartidningen; 1971 May; 68(21):2513-4. PubMed ID: 5556160
    [No Abstract]   [Full Text] [Related]  

  • 30. Testosterone in the treatment of arterial insufficiency of the lower limbs.
    Hentzer E; Madsen PC
    Scand J Clin Lab Invest Suppl; 1967; 99():198-206. PubMed ID: 4862833
    [No Abstract]   [Full Text] [Related]  

  • 31. Capillary diffusion capacity of sodium studied by the clearances of Na-24 and Xe-133 from hyperemic skeletal muscle in man.
    Lassen NA
    Scand J Clin Lab Invest Suppl; 1967; 99():24-6. PubMed ID: 6056928
    [No Abstract]   [Full Text] [Related]  

  • 32. Medical treatment of occlusive arterial disease of the legs. Walking exercise and medically induced hypertension.
    Larsen OA; Lassen NA
    Angiologica; 1969; 6(5):288-301. PubMed ID: 4899070
    [No Abstract]   [Full Text] [Related]  

  • 33. Intermittent claudication in diabetics: treatment with exercise and pentoxifylline--a 6-month, controlled, randomized trial.
    Belcaro G; Nicolaides AN; Griffin M; De Sanctis MT; Cesarone MR; Incandela L; Ippolito E; Pomante P; Geroulakos G; Ramaswami G
    Angiology; 2002; 53 Suppl 1():S39-43. PubMed ID: 11865835
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Trial of a novel prostacyclin analog, UT-15, in patients with severe intermittent claudication.
    Mohler ER; Klugherz B; Goldman R; Kimmel SE; Wade M; Sehgal CM
    Vasc Med; 2000; 5(4):231-7. PubMed ID: 11213235
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Treatment of long-distance intermittent claudication with pentoxifylline: a 12-month, randomized trial.
    De Sanctis MT; Cesarone MR; Belcaro G; Nicolaides AN; Griffin M; Incandela L; Bucci M; Geroulakos G; Ramaswami G; Vasdekis S; Agus G; Bavera P; Ippolito E
    Angiology; 2002; 53 Suppl 1():S13-7. PubMed ID: 11865829
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Vasodilator drugs and obliterating arterial diseases of the lower extremities].
    Larsen OA; Lassen NA
    Ugeskr Laeger; 1967 Sep; 129(36):1168-71. PubMed ID: 5598859
    [No Abstract]   [Full Text] [Related]  

  • 37. The effects of varying walking speeds when measuring the claudication distance on horizontal and sloping levels.
    Petersen FB
    Acta Chir Scand; 1967; 133(8):627-30. PubMed ID: 6081197
    [No Abstract]   [Full Text] [Related]  

  • 38. The effect of dextran-40 on capillary blood flow and capillary diffusion capacity in the anterior tibial muscle of subjects with intermittent claudication.
    Amtoft A
    Scand J Clin Lab Invest; 1973 May; 31(3):263-8. PubMed ID: 4201953
    [No Abstract]   [Full Text] [Related]  

  • 39. Muscle blood-flow studies by the technetium (99mTc) clearance technique in normal subjects and in patients with intermittent claudication.
    Cutajar CL; Brown NJ; Marston A
    Br J Surg; 1971 Jul; 58(7):532-7. PubMed ID: 5089967
    [No Abstract]   [Full Text] [Related]  

  • 40. [Pathogenetic hypotheses on pain in intermittent claudication].
    Lipparini R; Semeraro S; Di Feliciantonio R
    Arch Patol Clin Med; 1969 Sep; 45(6):463-83. PubMed ID: 5400268
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.